Aldeyra The (ALDX) vs Boundless Bio, Inc. (BOLD)
A side-by-side comparison of Aldeyra The and Boundless Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALDX
Aldeyra The
$0.92HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
BOLD
Boundless Bio, Inc.
$2.57HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ALDX vs BOLD
growth of $100 · dividends reinvested · last 3yALDX -70.0% (-33.1%/yr)BOLD -81.8% (-43.3%/yr)ALDX compounded faster over this window
ALDX BOLD
ALDX vs BOLD: by the numbers
- •BOLD is the larger company ($58M vs $55M market cap).
Metrics side by side
Valuation
| Metric | ALDX | BOLD |
|---|---|---|
| P/B ratio | 1.46 | 0.88 |
Profitability
| Metric | ALDX | BOLD |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -60.85% | -58.99% |
| ROIC | -63.52% | -43.97% |
Growth (annualized)
| Metric | ALDX | BOLD |
|---|---|---|
| Total return CAGR (5Y) | -36.54% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.